Disentangling the effects of race on breast cancer treatment
dc.contributor.author | Banerjee, Mousumi | en_US |
dc.contributor.author | George, Julie | en_US |
dc.contributor.author | Yee, Cecilia L. | en_US |
dc.contributor.author | Hryniuk, William M. | en_US |
dc.contributor.author | Schwartz, Kendra L. | en_US |
dc.date.accessioned | 2007-12-04T18:24:59Z | |
dc.date.available | 2009-01-07T20:01:16Z | en_US |
dc.date.issued | 2007-11-15 | en_US |
dc.identifier.citation | Banerjee, Mousumi; George, Julie; Yee, Cecilia; Hryniuk, William; Schwartz, Kendra (2007). "Disentangling the effects of race on breast cancer treatment." Cancer 110(10): 2169-2177. <http://hdl.handle.net/2027.42/57328> | en_US |
dc.identifier.issn | 0008-543X | en_US |
dc.identifier.issn | 1097-0142 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/57328 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17924374&dopt=citation | en_US |
dc.description.abstract | BACKGROUND. African Americans (AA) have higher mortality from breast cancer compared with white Americans (WA). Studies using population-based cancer registries have attributed this to disparities in treatment after normalizing the AA and WA populations for differences in disease stage. However, those studies were hampered by lack of comorbidity data and limited information about systemic treatments. The objective of the current study was to investigate racial disparities in breast cancer treatment by conducting a comprehensive medical records review of women who were diagnosed with breast cancer at the Karmanos Cancer Institute (KCI) in Detroit, Michigan. METHODS. The study cohort consisted of 651 women who were diagnosed with primary breast cancer between 1990 and 1996 at KCI. Multivariable logistic regression analysis controlling for sociodemographic factors, tumor characteristics, comorbidities, and health insurance status was used to assess whether there were differences between WA and AA in the receipt of breast-conserving surgery (BCS), radiation, tamoxifen, and chemotherapy. RESULTS. There was no significant difference between WA and AA in the receipt of BCS versus mastectomy. Patients with local-stage disease who were enrolled in government insurance plans underwent mastectomy more often (vs BCS plus radiation) compared with patients who were enrolled in nongovernment plans. The rates of receipt of tamoxifen and chemotherapy were similar for local-stage WA and local-stage AA. However, WA were more likely to receive tamoxifen and/or chemotherapy for regional-stage disease. Married women with regional disease were more likely to receive chemotherapy than nonmarried women. CONCLUSIONS. The results from this study may be used to target educational interventions to improve the use of adjuvant therapies among AA women who have regional-stage disease. Cancer 2007 © 2007 American Cancer Society. | en_US |
dc.format.extent | 106179 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | Disentangling the effects of race on breast cancer treatment | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan ; Fax: (734) 936-9582 ; Department of Biostatistics, School of Public Health, University of Michigan, 1420 Washington Heights, Ann Arbor, MI 48109-2029 | en_US |
dc.contributor.affiliationother | Department of Internal Medicine, Wayne State University, Detroit, Michigan ; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan | en_US |
dc.contributor.affiliationother | Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan | en_US |
dc.contributor.affiliationother | Cancer Advocacy Coalition of Canada, Toronto, Ontario, Canada | en_US |
dc.contributor.affiliationother | Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan ; Department of Family Medicine, Wayne State University, Detroit, Michigan | en_US |
dc.identifier.pmid | 17924374 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/57328/1/23026_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/cncr.23026 | en_US |
dc.identifier.source | Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.